Last reviewed · How we verify
Trivalent Influenza Virus Vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Trivalent Influenza Virus Vaccine (Trivalent Influenza Virus Vaccine) — MedImmune LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Trivalent Influenza Virus Vaccine TARGET | Trivalent Influenza Virus Vaccine | MedImmune LLC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Trivalent Influenza Virus Vaccine CI watch — RSS
- Trivalent Influenza Virus Vaccine CI watch — Atom
- Trivalent Influenza Virus Vaccine CI watch — JSON
- Trivalent Influenza Virus Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Trivalent Influenza Virus Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/trivalent-influenza-virus-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab